The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 05, 2008

Filed:

Mar. 29, 2007
Applicants:

Kenneth M. Boy, Durham, CT (US);

Shirong Zhu, Cheshire, CT (US);

John E. Macor, Guilford, CT (US);

Shuhao Shi, Madison, CT (US);

Samuel Gerritz, Guilford, CT (US);

Inventors:

Kenneth M. Boy, Durham, CT (US);

Shirong Zhu, Cheshire, CT (US);

John E. Macor, Guilford, CT (US);

Shuhao Shi, Madison, CT (US);

Samuel Gerritz, Guilford, CT (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 207/04 (2006.01); C07D 207/00 (2006.01); A01N 43/64 (2006.01); A01N 43/36 (2006.01);
U.S. Cl.
CPC ...
Abstract

There is provided a series of substituted N-aryl pyrrolidine derivatives of Formula (I) or a stereoisomer; or a pharmaceutically acceptable salt thereof, wherein R, R, R, R, R, R, R, R, and p as defined herein, their pharmaceutical compositions and methods of use. These compounds inhibit the processing of amyloid precursor protein (APP) by β-secretase and, more specifically, inhibit the production of Aβ-peptide. The present disclosure is directed to compounds useful in the treatment of neurological disorders related to β-amyloid production, such as Alzheimer's disease and other conditions affected by anti-amyloid activity.


Find Patent Forward Citations

Loading…